Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Now You See It ... Now You Don't


 
©2016 Abbott. All Rights Reserved.

Update: On March 18, 2017, the FDA released a letter to healthcare providers regarding an agency investigation about an increase rate of major adverse cardiac events (MACE) with Absorb BVS.

Read more here...



Dissolvable Heart Stent Offers New Option

The first dissolvable heart stent has made its way to Middle Tennessee, and cardiologists are singing its praises.

Unlike traditional metal stents, which remain in the artery for life, the Abbott Absorb™ stent is made of a naturally dissolving material, similar to dissolving stitches. It disappears in about three years, once the vessel has reformed. Saint Thomas Health, part of Ascension, has become the first hospital in Middle Tennessee to utilize the device, which was granted approval from the Food and Drug Administration in July 2016.

"This has been a long time coming," said Paul McMullan, MD, Saint Thomas Health interventional cardiologist who was the first to perform the procedure at the hospital using the fully bioresorbable drug eluting coronary stent. McMullan said that, like most new devices, the manufacturer has been slow and intentional in its rollout to avoid overutilization and misuse, and to ensure cardiologists are well trained on the new device. "We're still not using it routinely, and we're selecting patients very carefully," said McMullan, who has placed a handful of dissolvable stents since his first case in October.


Pros & Cons

While the dissolvable stent is an impressive medical breakthrough, it's not for everyone. "The whole point of the dissolvable stent is that it will go away in a few years, so if you've got an elderly patient there's not a great benefit," McMullan explained. "Younger patients will benefit more."


Paul McMullan, MD

Technical difficulty also comes into play, meaning ease of deliverability and the size and shape of the vessel. Patients also must be able to comply with medical therapies. Similar to the newer metal stents, the dissolvable model is coated with a drug to reduce scarring. However, patients are still required to take blood thinners for one year or more, and those with bleeding issues or who simply can't comply with medication maintenance aren't likely candidates. Short-term medical risks of the dissolvable stent are similar to those of its metal predecessors, and surgical implementation and patient recovery are both identical.

"The biggest benefit is that there's no metal in the vessel long term," McMullan said. "When we put multiple stents in arteries, it becomes more and more difficult over the years because multiple stent layers can become problematic and prevent us from getting to the new blockage." That's often the case for stent patients who require open-heart surgery down the road.


The Role of Stents

"Before stents, the vessel could tear and shut down blood flow when opened up by a balloon ... or you would blow it up, and a narrow vessel would shrink back to where it started," McMullan said of pre-stent angioplasty.

"The game-changing role of stents is that they keep the artery where you put it. If there's a tear, the stent keeps it from flopping out and shutting out blood flow. Radial force keeps it pushed out and held in place," he continued. Over time the vessel heals and forms to its new size, and radial force is no longer needed to keep it in place.

"God made blood vessels to respond to our body's needs," McMullan said. "As the heart contracts and relaxes, the flexing of those vessels is what helps control blood delivery. With dissolvable stents, that function shortly returns, and the vessel retains the phase of motion functionality that you can't have with long-term rigid stents."


Looking Back, Looking Ahead

In discussing the new stent with patients, McMullan said safety and comparability to other stents are always primary concerns. While bare metal stents were first introduced in the early 1990s, they often triggered growth of scar build up, or restenosis, within the stent. The availability of drug-coated stents around 2001 meant less scar tissue but still required patients to take blood thinners for a year or longer, and the stent stuck around for life.

Although still relatively rigid, the new stent is the best today's cardiologists have to offer eligible angioplasty patients. And while deliverability remains the biggest hurdle for stents in general, McMullan expects that to become more streamlined as the science behind stents continues to unfold.

"We'll see new technology like this gradually take root and become more widely utilized in patient care, and physicians will become more comfortable with it with use," he said. "Data from long term trials also will allow us to treat with confidence and will influence more utilization of this device."

WEB:
Abbott Absorb
Saint Thomas Heart
Saint Thomas Health

 
Share:

Related Articles:


Recent Articles

Alexander: Bipartisan Legislation Will Lower What Americans Pay Out of Their Own Pockets for Health Care

The Lower Health Care Costs Act of 2019 contains nearly three dozen proposals from at least 16 Republican, 14 Democrat senators

Read More

If You Build It, They Will Come

Middle Tennessee's healthcare options continue to expand through new construction and facility renovations and additions.

Read More

Lease, Build, Buy, Sell: Finding the Best Fit for Each Medical Practice

When it comes to medical real estate, there is no one 'right' answer for every practice. Instead, experts say it's important to understand all the options before making a decision that impacts individual physicians, the practice ... and ultimately, patients.

Read More

Dr. Jerry Tannenbaum: Redefining, Redesigning Nephrology

Innovative building models and telemedicine mean better care for patients nationwide.

Read More

Wayfinding in Healthcare

With expansions, renovations and additions to healthcare facilities over time, the ability to easily navigate a campus is often lost along the way. Taking time to consider wayfinding can vastly improve the way patients, visitors and staff engage with the environment.

Read More

Building Walls

Steve Ward & Associates prefab headwalls mean more savings, options for healthcare clients.

Read More

LipiFlow®: Advanced Procedure to Treat Meibomian Gland Dysfunction & Chronic Dry Eye

In-office procedure can promote eyelid health and provide relief from dry eye.

Read More

SCALE 2019 Showcases Latest in Aesthetics Medicine

Now in its 14th year, the Music City SCALE Conference broke previous attendance records, with plans for additional growth in 2020.

Read More

Rethinking the Approach to Acne

New options and research have changed the traditional approach to treating acne.

Read More

Financing the Deal

Healthcare investment experts gathered for the Nashville Health Care Council's annual Financing the Deal panel focused on private equity trends and strategies.

Read More

Email Print
 
 

 

 


Tags:
Abbott Absorb, Coronary Stent, Dissolvable Stent, Paul McMullan, Saint Thomas Health Cardiology, Saint Thomas Heart
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: